Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on July 6, 2006
J Am Soc Nephrol 17: 2112-2119, 2006
© 2006 American Society of Nephrology
doi: 10.1681/ASN.2006030204

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2006030204v1
17/8/2112    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amann, K.
Right arrow Articles by Ritz, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amann, K.
Right arrow Articles by Ritz, E.

Frontiers in Nephrology

Cross-Talk between the Kidney and the Cardiovascular System

Kerstin Amann*, Christoph Wanner{dagger} and Eberhard Ritz{ddagger}

* Department Pathology, Friedrich-Alexander University Erlangen, Erlangen, {dagger} Department of Internal Medicine, Julius-Maximilian University Würzburg, Würzburg, and {dagger} Department of Internal Medicine, Ruperto-Carola University, Heidelberg, Germany

Address correspondence to: Prof. Eberhard Ritz, Department Internal Medicine, Nierenzentrum, Im Neuenheimer Feld 162, 69120 Heidelberg, Germany. Phone: +49-6221-601705; Fax: +49-6221-603302; E-mail prof.e.ritz{at}t-online.de

In recent years, increasing evidence has been provided that even minor renal dysfunction is a powerful cardiovascular risk factor that induces typical cardiovascular alterations and thus predisposes to coronary heart disease as well as to noncoronary cardiovascular problems. This first had been noted in patients with diabetes but now has been confirmed amply in patients without diabetes as well. Numerous heterogeneous abnormalities have been described in patients with early renal dysfunction (e.g., microalbuminuria, reduced estimated GFR). One final common pathway seems to be endothelial cell dysfunction. The link between albuminuria and generalized endothelial cell dysfunction (as indicated by diminished flow-mediated vasodilation, markers of endothelial cell dysfunction, sloughed off endothelial cells, and high transcapillary albumin escape rate) is unclear. In patients with early renal dysfunction, a long list of classical and nonclassical cardiovascular risk factors have been identified: Elevated asymmetric dimethyl-L-arginine concentrations, markers of microinflammation, oxidative stress, features of metabolic syndrome, abnormal adipokine concentrations, dyslipidemia, inappropriate activation of the renin-angiotensin system, and sympathetic overactivity. The mechanisms that link dysfunction of the kidney and the cardiovascular system are being sought. The most interesting unifying concept, however, is deranged fetal programming linking nephron underdosing to the increased cardiovascular risk.




This article has been cited by other articles:


Home page
CJASNHome page
S. R. Orth and S. I. Hallan
Smoking: A Risk Factor for Progression of Chronic Kidney Disease and for Cardiovascular Morbidity and Mortality in Renal Patients Absence of Evidence or Evidence of Absence?
Clin. J. Am. Soc. Nephrol., January 1, 2008; 3(1): 226 - 236.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
S. Hallan, B. Astor, S. Romundstad, K. Aasarod, K. Kvenild, and J. Coresh
Association of Kidney Function and Albuminuria With Cardiovascular Mortality in Older vs Younger Individuals: The HUNT II Study
Arch Intern Med, December 10, 2007; 167(22): 2490 - 2496.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
A. Singh, S. C. Satchell, C. R. Neal, E. A. McKenzie, J. E. Tooke, and P. W. Mathieson
Glomerular Endothelial Glycocalyx Constitutes a Barrier to Protein Permeability
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2885 - 2893.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. G. Couser
Chronic Kidney Disease The Promise and the Perils
J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2803 - 2805.
[Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. P. de Caestecker
Angiopoietin-2 and Glomerular Proteinuria
J. Am. Soc. Nephrol., August 1, 2007; 18(8): 2217 - 2218.
[Full Text] [PDF]


Home page
CirculationHome page
E. L. Schiffrin, M. L. Lipman, and J. F.E. Mann
Chronic Kidney Disease: Effects on the Cardiovascular System
Circulation, July 3, 2007; 116(1): 85 - 97.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. P. Donahue, S. Stranges, K. Rejman, L. B. Rafalson, J. Dmochowski, and M. Trevisan
Elevated Cystatin C Concentration and Progression to Pre-Diabetes: The Western New York Study
Diabetes Care, July 1, 2007; 30(7): 1724 - 1729.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
D. de Zeeuw, H.-H. Parving, and R. H. Henning
Microalbuminuria as an Early Marker for Cardiovascular Disease
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2100 - 2105.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP